home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Drug Discovery Week Europe (DDWE)

 
  June 28, 2013  
     
 
GTC Conferences, Kempinski Hotel Bristol Berlin, Berlin, Germany
Oct 7-10, 2013


Drug Discovery Week Europe
October 7-10, 2013


Register for the week and attend both summits!

 
NGS & Bioinformatics Europe Summit 2013
October 7-8
Biomarker Europe Summit 2013
October 9-10


Conferences:
• 
Next-Generation Sequencing: Opportunities & Challenges 
• 
Bioinformatics & Data Management


Conferences:

• 
2nd Biomarkers in Diagnostics 
• 
7th Biomarkers in Drug Discovery & Development

 
October 7- October 8
NGS & Bioinformatics Europe Summit 2013
Next Generation Sequencing:
Opportunities & Challenges Conference
Bioinformatics & Data Management Conference

• Joint Session: Applications of NGS Platforms
• 
Joint Session: NGS in Cancer
• 
Transcriptomics & RNA Sequencing
• 
Pharmacogenomics & Clinical Applications
• 
Joint Session: Health Technology Assessment 
• 
NGS in Ancient & Forensic DNA

Click here for a detailed agenda


 

• Joint Session: Applications of NGS Platforms
• 
Joint Session: NGS in Cancer
• 
Big Data & Cloud-Enabled Solutions
• 
Data Interpretation
• 
Joint Session: Health Technology Assessment 
• 
Data Integration

Click here for a detailed agenda

 
October 9- October 10
Biomarker Europe Summit 2013
2nd Biomarkers in Diagnostics Conference7th Biomarkers in Drug Discovery & Development Conference

• New Diagnostic Biomarkers & Their Development
• 
Novel Diagnostic Technologies
• 
Predictive VS Prognostic Biomarkers in Personalized
  Medicine
• 
Biomarkers for Personalized Prevention Strategies
• 
Next Generation Sequencing in the Clinic
• 
Companion Diagnostics Development & Partnering
• 
Prospects of Systems Medicine in Personalized Medicine

Click here for a detailed agenda

• Biomarker Discovery & Identification Strategies
• 
Biomarkers to Validate Potential Drug Targets
• 
Safety, Efficacy and PK/PD Biomarkers in Drug
wDevelopment

• 
Biomarkers as Surrogate Endpoints
• 
Applications of Imaging Biomarkers & Tracers
• 
The Statistics Methods Underlying SuccessfulwBiomarker Discovery and Validation
• 
Overcoming Challenges of Clinical Translation – wCase Studies

Click here for a detailed agenda

 


 
 
Organized by: GTC Conferences
Invited Speakers:
Register by August 9th, 2013 for a 20% Discount. Or register 2 and the 3rd goes FREE with the coupon code RCDVB!

 
KEYNOTE SPEAKERS
 
 
Mostafa Ronaghi
Senior Vice President & Chief Technology Officer
Illumina
Scott Kennedy
Vice President and Global Head of Biomarker Development Translational Medicine
Novartis Institutes for Biomedical Research Inc.

Richard Buller
Vice President and Head, Clinical Development 
Oncology Business Unit
Pfizer
 
FEATURED SPEAKERS
 
 
Patrick Descombes
Head of Functional Genomics Core
Nestlé Institute of Health Sciences SA
Raimo Tanzi
Director of NGS Business Development
Life Technologies
  
DISTINGUISHED SPEAKERS
 
 
Markus Beier
VP Strategy & IP
Comprehensive Biomarker Center GmbH
 
 
Daniel Chelsky
Chief Scientific Officer
Caprion
 
 
Kevin Cox
CEO
Imanova
 
 
Manfred Dietel
Professor, Institute of Pathologe
Charité – Universitätsmedizin Berlin
 
 
Hueseyin Firat
President & CEO
Firalis
 
 
Davina Gale
University of Cambridge
 
 
Joachim Greue
Partner
Bioscience Valuation BSV GmbH
 
 
Franz Hessel
Professor, Healthcare Management
SRH Hochschule Berlin
 
 
Graham Jackson 
MRC Programme Leader
MRC Prion Unit and Department of Neurodegenerative Disease
 
Hans Lehrach
Max Planck Institute for Molecular Genetics
 
 
Michael Lutz
CEO
Lophius Biosciences
 
 
Heiko Niessen
Principal Translational Medicine Expert & Teamleader Clinical Imaging
Boehringer Ingelheim Pharma GmbH & Co. KG
 
 
Winfried Maerz 
Synlab
 
 
Pierluigi Mauri
Doctor, Proteomics and Metabolomics
Institute for Biomedical Technologies (ITB-CNR)
 
 
Matthew Morrison
Biology Manager – UK
Medical Diagnostics
 
 
Christoph Petry
Geschaftsfuhrer and CEO
Sividon Diagnostics GmbH
 
 
Stephan Schwers
Head of Assay Technologies, Global Biomarkers - Clinical Sciences
 Bayer AG
 
 
Birgitte Søgaard
Divisional Director, Clinical & Quantitative Pharmacology
H. Lundbeck A/S
 
 
Laszlo Takacs
CEO
Biosystems International Kft.
 
 
Alain van Gool
Head Radboud Proteomics Centre, Laboratory of Genetic, Endocrine and Metabolic Disease
University Medical Center St. Radboud
 
 
Hans-Dieter Volk
Director, Institute of Medical Immunology & Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
Charité Universitätsmedizin
 
 
Paul Whittaker
Director and Unit Head Pre-Clinical Biomarkers
Novartis
 
 
Marion Wiesmann
Oncolgy Director
Novartis
 
 
Hai Zhang
Global Business Development
Roche
 
 
Wilhelm Ansorge 
Professor
Ecole Polytechnique Federale de Lausanne 
 
 
Tomas Babak
Senior Research Scientist, Biology
Stanford University
 
 
Bert Bakker
Head of Laboratory for Diagnostic Genome Analyses 
Leiden University Medical Center
 
 
Guy Barker
Associate Professor, School of Life Sciences
The University of Warwick
 
 
Jay Bergeron
Scientific Systems Analyst & Engineer
Pfizer
 
 
John Castle
Head of Biomarker Development Center
Translational Oncology, Johannes Gutenberg University of Mainz
 
 
Jean-Baptiste Cazier
Bioinformatics Core Group Leader
University of Oxford
 
 
Francesca Cordero
Researcher, Informatics
University of Torino, Italy
 
 
 Vanessa Hayes
Professor of Genomic Medicine
J. Craig Venter Institute
 
 
Hans-Rudolf Hotz
Bioinformatics Support
Galaxy Project, Friedrich Miescher Institute for Biomedical Research
 
 
Daniel Huson
Professor of Algorithms in Bioinformatics
University in Tübingen
 
 
Ian Jacob 
Research Associate in Health Economics 
Manchester Centre for Health Economics
 
 
Scott Kahn
Chief Information Officer
Illumina
 
 
Bart Keijser
Senior Research Scientist
 TNO, The Netherlands
 
 
Teri Klein
Project Director, PharmGKB & Senior Research Scientist
Stanford University
 
 
Johannes Krause
Junior Professor
Eberhard Karls University of Tübingen
 
 
Kai Lao
Director R&D/Principal Scientist, Molecular Biology Department, Genetic Systems
Applied Biosystems, part of Life Technologies
 
 
Janis Landry-Lane
Program Director, World-wide Technical Computing, Life Sciences
IBM
 
 
Frank N Lee
Higher Education Segments
IBM
 
 
Andrew Litt
Chief Medical Officer, Healthcare and Life Sciences
Dell
 
 
Dirk Loeffert
Vice President, Head of Sample & Assay Platform Technologies Global R&D
Qiagen
 
 
Robert Loewe
Chief Executive Officer
GeneWake GmbH
 
 
Anton Nekrutenko
Associate Professor of Biochemistry and Molecular Biology 
Penn State University
 
 
Len Pennacchio
Deputy Director & Senior Staff Scientist, Genomics Division 
Joint Genome Institute 
 
 
Bernhard Y. Renard
Group Leader, Bioinformatics Research Group
Robert Koch-Institute
 
 
Wolfgang Sadee
Director of Pharmacogenomics Center
Ohio State University
 
 
Frank Schacherer
Chief Technology Officer
BioBase International
 
 
Masateru Taniguchi
Professor 
Institute of Scientific and Industrial Research
 
 
Ruthild Weber
Professor, Department of Human Genetics 
Hannover Medical School
 
 
Stefan Wiemann
Group Leader
German Cancer Research Center
 
 
Eske Willerslev
Director 
Statens Naturhistoriske Museum
 
 
Elizabeth Worthey
Director of Genomic Informatics at Medical College of Wisconsin
University of Wisconsin
 
Deadline for Abstracts: September 7-10, 2013
 
Registration: https://www.gtcbio.com/register/drug-discovery-week-europe
E-mail: infogtcbio@gtcbio.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.